Definitive Healthcare Future Growth
Future criteria checks 0/6
Definitive Healthcare's revenue is forecast to decline at 1.4% per annum while its annual earnings are expected to grow at 96.6% per year. EPS is expected to grow by 100.1% per annum. Return on equity is forecast to be 6.6% in 3 years.
Key information
96.6%
Earnings growth rate
100.1%
EPS growth rate
| Healthcare Services earnings growth | 31.0% |
| Revenue growth rate | -1.4% |
| Future return on equity | 6.6% |
| Analyst coverage | Good |
| Last updated | 18 Nov 2024 |
Recent future growth updates
Recent updates
Definitive Healthcare: Poor Near-Term Outlook, But New CEO May Change Things
Aug 19More Unpleasant Surprises Could Be In Store For Definitive Healthcare Corp.'s (NASDAQ:DH) Shares After Tumbling 28%
Aug 01
Definitive Healthcare: Weak Near-Term Growth To Put Valuation In Rangebound
Jun 25Risks Still Elevated At These Prices As Definitive Healthcare Corp. (NASDAQ:DH) Shares Dive 26%
May 30Pinning Down Definitive Healthcare Corp.'s (NASDAQ:DH) P/S Is Difficult Right Now
Apr 14Definitive Healthcare: Reiterate Buy Rating As I Expect Growth To Recover In FY25
Mar 19Is Definitive Healthcare (NASDAQ:DH) Using Debt In A Risky Way?
Feb 16An Intrinsic Calculation For Definitive Healthcare Corp. (NASDAQ:DH) Suggests It's 42% Undervalued
Dec 29Definitive Healthcare Corp. (NASDAQ:DH) Stock Rockets 31% As Investors Are Less Pessimistic Than Expected
Nov 24Estimating The Fair Value Of Definitive Healthcare Corp. (NASDAQ:DH)
Jun 02Definitive Healthcare Corp. (NASDAQ:DH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
May 06A Look At The Fair Value Of Definitive Healthcare Corp. (NASDAQ:DH)
Dec 08Definitive Healthcare Grows Headcount Despite Gathering Recession Clouds
Aug 31Definitive Healthcare Corp.'s (NASDAQ:DH) Intrinsic Value Is Potentially 27% Above Its Share Price
Jul 17Definitive Healthcare: No Involvement Yet Here
Jun 05Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 250 | -17 | 105 | 96 | 8 |
| 12/31/2025 | 241 | -20 | 83 | 93 | 12 |
| 12/31/2024 | 250 | -437 | 61 | 69 | 12 |
| 9/30/2024 | 256 | -364 | 53 | 55 | N/A |
| 6/30/2024 | 258 | -405 | 43 | 45 | N/A |
| 3/31/2024 | 256 | -200 | 41 | 43 | N/A |
| 12/31/2023 | 251 | -202 | 38 | 41 | N/A |
| 9/30/2023 | 246 | -182 | 25 | 32 | N/A |
| 6/30/2023 | 238 | -14 | 25 | 33 | N/A |
| 3/31/2023 | 232 | -11 | 28 | 37 | N/A |
| 12/31/2022 | 223 | -7 | 27 | 36 | N/A |
| 9/30/2022 | 208 | -27 | 39 | 44 | N/A |
| 6/30/2022 | 194 | -32 | 29 | 32 | N/A |
| 3/31/2022 | 179 | -16 | 22 | 25 | N/A |
| 12/31/2021 | 166 | -18 | 18 | 25 | N/A |
| 9/30/2021 | 153 | -8 | 24 | 30 | N/A |
| 6/30/2021 | 140 | N/A | 26 | 31 | N/A |
| 3/31/2021 | 128 | 2 | 25 | 30 | N/A |
| 12/31/2020 | 118 | N/A | 22 | 23 | N/A |
| 12/31/2019 | 86 | -36 | 20 | 22 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DH is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: DH is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: DH is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: DH's revenue is expected to decline over the next 3 years (-1.4% per year).
High Growth Revenue: DH's revenue is forecast to decline over the next 3 years (-1.4% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: DH's Return on Equity is forecast to be low in 3 years time (6.6%).